Main menu

NEW YORK, May 23 – Promega marked its entry into the genotyping market Wednesday, announcing that it would make its ReadIt system commercially available to select laboratories.

“We are now launching a controlled sales program where we carefully identify our prospect and offer a lot of support and help,” said Richard Schifreen, business unit leader for Promega’s molecular diagnostics business.